Lead Author: Wood
Summary: The American Kidney Fund (AKF) is primarily funded by the two largest dialysis providers in the US — DaVita and Fresenius. AKF steers dialysis patients from Medi-Cal and toward private insurance, where the reimbursement rates they receive are much higher. This practice has helped enable these two companies to make profits exceeding four billion dollars since 2017. AB290 stops this heinous, price-gouging practice and will benefit both patients and taxpayers. This bill passed and was signed into law.